Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Senores Pharmaceuticals reported sharp Q4 FY26 growth and outlined deal updates, while the stock traded lower and stayed close to its 52-week high range on May 14, 2026.
Dr. Agarwal’s Health Care will consider unaudited Q3 FY26 results on February 3, 2026, and hold an earnings call on February 4 at 11:30 AM IST.
PNB Housing Finance moved higher after Q4 FY26 results as brokerages reiterated bullish calls, citing a profit beat, improving asset quality, and retail-led growth momentum.
Brokerages remain split on Hindalco, balancing stronger aluminium pricing and India demand against Novelis near-term uncertainty, US tariff headwinds, and mixed profitability trends.
Cipla led the Nifty gainers after Q4 FY26 results, as brokerages highlighted India growth and US pipeline visibility even as profits and margins declined year-on-year.
eMudhra’s ₹412.79 crore book-built IPO at ₹243-256 opened May 20, 2022, listed June 1 at ₹270-271, and traded ₹689.65 on Sept 10, 2025.
Vishal Mega Mart posted Q4FY26 PAT of ₹168 crore on revenue of ₹3,114 crore, with EBITDA rising to ₹424.6 crore even as margin eased to 13.6%.
Sunil Bharti Mittal outlined a plan to consolidate Bharti Airtel promoter holdings under Bharti Telecom, while Singtel pares its direct stake to reach ownership parity.
PNB Gilts surged after a report said the RBI has urged the Finance Ministry to cut taxes on foreign bond investors, aiming to attract inflows and support the rupee.
Vishal Mega Mart’s Q4FY26 profit rose 46% to ₹168 crore as revenue grew 22.2% to ₹3,114 crore, while EBITDA margin eased to 13.6%.
Government royalty cuts on crude oil and gas production lifted ONGC and Oil India shares, with CLSA estimating a 7-11% fair-value upside from higher realisations.
Aurobindo Pharma’s subsidiary Eugia received USFDA final approval for Dasatinib tablets, a Sprycel generic, with a Q1 FY26 launch as the group deepens its US oncology presence.
Borosil Renewables is scaling solar glass capacity by 60% with a ₹950 crore brownfield project, as India Ratings upgrades its outlook amid improving margins and steady demand.
Geojit reiterated a BUY on Grasim with a ₹3,133 target after Q2FY26 margin-led earnings growth, while brokerages tracked paints scaling and UltraTech’s expansion plans.
DLF plans to spend ₹23,500 crore to finish launched housing projects in Delhi-NCR and Mumbai, after FY25 record bookings and multiple luxury sell-outs.
Laurus Labs saw wide price swings alongside strong FY26 earnings and CDMO growth, while profit-taking, export softness, and mixed broker calls kept the stock volatile.
